» Articles » PMID: 24247158

Curcumin-loaded Nanoparticles Enhance Apoptotic Cell Death of U2OS Human Osteosarcoma Cells Through the Akt-Bad Signaling Pathway

Overview
Journal Int J Oncol
Specialty Oncology
Date 2013 Nov 20
PMID 24247158
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin has potential anticancer activity and has been shown to be involved in several signaling pathways including differentiation and apoptosis. Our previous study showed that water-soluble PLGA curcumin nanoparticles (Cur-NPs) triggered apoptotic cell death through regulation of the function of MDR1 and the production of reactive oxygen species (ROS) in cisplatin-resistant human oral cancer CAR cells. In this study, we investigated the anti-proliferative effects of Cur-NPs on human osteosarcoma U2OS cells. The morphology of Cur-NPs showed spherical shape by TEM analysis. The encapsulation efficiency of curcumin in Cur-NPs prepared by single emulsion was 90.5 ± 3.0%. Our results demonstrated that the curcumin fragments on the mass spectrum of Cur-NPs and the peaks of curcumin standard could be found on the Cur-NPs spectrum by 1H-NMR spectra analysis. Cur-NPs induced anti-proliferative effects and apoptosis in U2OS cells. Compared to the untreated U2OS cells, more detectable amount of Cur-NPs was found inside the treated U2OS cells. Cur-NPs induced DNA fragmentation and apoptotic bodies in U2OS cells. Both the activity and the expression levels of caspases-3/-7 and caspase-9 were elevated in the treated U2OS cells. Cur-NPs upregulated the protein expression levels of cleaved caspase-3/caspase-9, cytochrome c, Apaf-1 and Bad and downregulated the protein expression level of p-Akt in U2OS cells. These results suggest Cur-NPs are effective in enhancing apoptosis in human osteosarcoma cells and thus could provide potential for cancer therapeutics.

Citing Articles

Cytotoxicity Enhancement in Osteosarcoma with Multifunctional I-131 Radiotherapeutic Nanoparticles: In Vitro Three-Dimensional Spheroid Model and Release Kinetics Modeling.

Marshall S, Taweesap M, Saelim B, Pachana V, Benlateh N, Sangangam S Molecules. 2024; 29(3).

PMID: 38338373 PMC: 10856476. DOI: 10.3390/molecules29030630.


Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.

Akbari P, Taebpour M, Akhlaghi M, Hasan S, Shahriyari S, Parsaeian M Med Oncol. 2024; 41(3):68.

PMID: 38289404 DOI: 10.1007/s12032-023-02291-4.


Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.

Lu K, Lu P, Lu E, Lin C, Yang S Int J Biol Sci. 2023; 19(4):1241-1265.

PMID: 36923933 PMC: 10008701. DOI: 10.7150/ijbs.80590.


The roles of glycolysis in osteosarcoma.

Feng Z, Ou Y, Hao L Front Pharmacol. 2022; 13:950886.

PMID: 36059961 PMC: 9428632. DOI: 10.3389/fphar.2022.950886.


The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.

Zahedipour F, Bolourinezhad M, Teng Y, Sahebkar A J Oncol. 2021; 2021:3006853.

PMID: 34671398 PMC: 8523229. DOI: 10.1155/2021/3006853.